Concepedia

An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine

Robert T. Schoen, Terry Deshefy‐Longhi, Christian Van-Hoecke, Charles Buscarino, Erol Fikrig

Clinical Therapeutics · 2003 · 15 citations · 12 references

DOI

Concepts

References

12

Vaccination against Lyme Disease with Recombinant<i>Borrelia burgdorferi</i>Outer-Surface Lipoprotein A with Adjuvant

Allen C. Steere, Vijay K. Sikand, François Meurice et al. · New England Journal of Medicine · 1998 · 748 citations · Full text

, , +16

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis

Dawn M. Gross, Thomas G. Forsthuber, Magdalena Tary‐Lehmann et al. · Science · 1998 · 521 citations

, , +17

A Vaccine Consisting of Recombinant<i>Borrelia burgdorferi</i>Outer-Surface Protein A to Prevent Lyme Disease

Leonard H. Sigal, John M. Zahradnik, Philip T. Lavin et al. · New England Journal of Medicine · 1998 · 398 citations · Full text

, , +17

Underreporting of Lyme Disease by Connecticut Physicians, 1992

James Meek, Christine L. Roberts, Everett V. Smith et al. · Journal of Public Health Management and Practice · 1996 · 103 citations

, , +11

Statistical considerations in the quantitation of serum immunoglobulin levels using the Enzyme-Linked Immunosorbent Assay (ELISA)

K. Karpinski, Simon W. Hayward, Helen Tryphonas · Journal of Immunological Methods · 1987 · 94 citations

, , +12